Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2025-12-31 @ 4:18 AM
Study NCT ID:
NCT05361668
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-31
First Post:
2022-04-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome
Sponsor:
Crinetics Pharmaceuticals Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-22
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-02
Completion Date Type:
ESTIMATED
First Submit Date:
2022-04-27
First Submit QC Date:
None
Study First Post Date:
2022-05-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-07-10
Results First Submit QC Date:
None
Results First Post Date:
2025-10-31
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-03
Last Update Post Date:
2025-10-31
Last Update Post Date Type:
ESTIMATED